Willem P. C. Stemmer | |
|---|---|
| Born | March 12, 1957[1] |
| Died | April 2, 2013 |
| Nationality | Dutch |
| Alma mater | University of Wisconsin–Madison |
| Known for | DNA shuffling, Maxygen |
| Awards | Charles Stark Draper Prize (2011) |
| Scientific career | |
| Institutions | Amunix |
Willem P. C. "Pim" Stemmer (12 March 1957 – 2 April 2013)[2] was a Dutch scientist and entrepreneur who invented numerous biotechnologies. He was the founder and CEO of Amunix Inc., a company that creates "pharmaceutical proteins with extended dosing frequency".[3] His other prominent inventions include DNA shuffling, now referred to as molecular breeding. He holds more than 97 patents.[3] Stemmer was honored with the Charles Stark Draper Prize in 2011 for the pioneering contributions to directed evolution which won the Nobel Prize in Chemistry in 2018.[4] He was elected as member of National Academy of Engineering.
Stemmer died of cancer on April 2, 2013.[5]
- ^ Memorial Tributes Volume 18. 2014. doi:10.17226/18959. ISBN 978-0-309-31291-2.
- ^ James W Larrick, Volker Schellenberger & Carlos F Barbas III (2013) Willem 'Pim' Stemmer 1957–2013, Nature Biotechnology 31, 584.
- ^ a b "Willem P. C. Stemmer". National Academy of Engineering. Retrieved 27 January 2013.
- ^ Chang, Kenneth (3 October 2018). "Use of Evolution to Design Molecules Nets Nobel Prize in Chemistry for 3 Scientists". The New York Times.
- ^ "Willem Stemmer Obituary". San Jose Mercury News/San Mateo County Times. 21 April 2013. Retrieved 21 May 2013.